Gholami M - Search Results

1

Theranostic α-Lactalbumin-Polymer-Based Nanocomposite as a Drug Delivery Carrier for Cancer Therapy.

Delavari B, Bigdeli B, Mamashli F, Gholami M, Bazri B, Khoobi M, Ghasemi A, Baharifar H, Dehghani S, Gholibegloo E, Amani A, Riahi-Alam N, Ahmadian S, Goliaei B, Asli NS, Rezayan AH, Saboury AA, Varamini P. Delavari B, et al. Among authors: gholami m. ACS Biomater Sci Eng. 2019 Oct 14;5(10):5189-5208. doi: 10.1021/acsbiomaterials.9b01236. Epub 2019 Sep 23. ACS Biomater Sci Eng. 2019. PMID: 33455225

2

Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.

Rastegar R, Akbari Javar H, Khoobi M, Dehghan Kelishadi P, Hossein Yousefi G, Doosti M, Hossien Ghahremani M, Shariftabrizi A, Imanparast F, Gholibeglu E, Gholami M. Rastegar R, et al. Among authors: gholami m. Artif Cells Nanomed Biotechnol. 2018;46(sup2):207-216. doi: 10.1080/21691401.2018.1453829. Epub 2018 Apr 24. Artif Cells Nanomed Biotechnol. 2018. PMID: 29688063

3

Combination Therapy of Breast Cancer by Codelivery of Doxorubicin and Survivin siRNA Using Polyethylenimine Modified Silk Fibroin Nanoparticles.

Norouzi P, Motasadizadeh H, Atyabi F, Dinarvand R, Gholami M, Farokhi M, Shokrgozar MA, Mottaghitalab F. Norouzi P, et al. Among authors: gholami m. ACS Biomater Sci Eng. 2021 Mar 8;7(3):1074-1087. doi: 10.1021/acsbiomaterials.0c01511. Epub 2021 Feb 4. ACS Biomater Sci Eng. 2021. PMID: 33539074

4

Dual drug delivery system of teicoplanin and phenamil based on pH-sensitive silk fibroin/sodium alginate hydrogel scaffold for treating chronic bone infection.

Motasadizadeh H, Tavakoli M, Damoogh S, Mottaghitalab F, Gholami M, Atyabi F, Farokhi M, Dinarvand R. Motasadizadeh H, et al. Among authors: gholami m. Biomater Adv. 2022 Aug;139:213032. doi: 10.1016/j.bioadv.2022.213032. Epub 2022 Jul 16. Biomater Adv. 2022. PMID: 35882123

5

Neuroprotective Effect of Propolis Polyphenol-Based Nanosheets in Cellular and Animal Models of Rotenone-Induced Parkinson's Disease.

Mamashli F, Meratan AA, Ghasemi A, Obeidi N, Salmani B, Atarod D, Pirhaghi M, Moosavi-Movahedi F, Mohammad-Zaheri M, Shahsavani MB, Habibi-Kelishomi Z, Goliaei B, Gholami M, Saboury AA. Mamashli F, et al. Among authors: gholami m. ACS Chem Neurosci. 2023 Mar 1;14(5):851-863. doi: 10.1021/acschemneuro.2c00605. Epub 2023 Feb 7. ACS Chem Neurosci. 2023. PMID: 36750431

6

NSF evaluation of gadolinium biodistribution in renally impaired rats: Using novel metabolic Gd2O3 nanoparticles coated with β-cyclodextrin (Gd2O3@PCD) in MR molecular imaging.

Ashouri H, Riyahi Alam N, Khoobi M, Haghgoo S, Rasouli Z, Gholami M. Ashouri H, et al. Among authors: gholami m. Magn Reson Imaging. 2024 Apr;107:120-129. doi: 10.1016/j.mri.2024.01.003. Epub 2024 Jan 11. Magn Reson Imaging. 2024. PMID: 38215955

7

Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy.

Mottaghitalab F, Kiani M, Farokhi M, Kundu SC, Reis RL, Gholami M, Bardania H, Dinarvand R, Geramifar P, Beiki D, Atyabi F. Mottaghitalab F, et al. Among authors: gholami m. ACS Appl Mater Interfaces. 2017 Sep 20;9(37):31600-31611. doi: 10.1021/acsami.7b10408. Epub 2017 Sep 5. ACS Appl Mater Interfaces. 2017. PMID: 28836425

8

Molecular and Biochemical Evidences for Beneficial Effects of Zinc Oxide Nanoparticles in Modulation of Chlorpyrifos Toxicity in Human Lymphocytes.

Navaei-Nigjeh M, Gholami M, Fakhri-Bafghi MS, Baeeri M, Abdollahi M. Navaei-Nigjeh M, et al. Among authors: gholami m. Iran J Pharm Res. 2018 Summer;17(3):927-939. Iran J Pharm Res. 2018. PMID: 30127816 Free PMC article.

9

α-Lipoic acid prevents senescence, cell cycle arrest, and inflammatory cues in fibroblasts by inhibiting oxidative stress.

Baeeri M, Bahadar H, Rahimifard M, Navaei-Nigjeh M, Khorasani R, Rezvanfar MA, Gholami M, Abdollahi M. Baeeri M, et al. Among authors: gholami m. Pharmacol Res. 2019 Mar;141:214-223. doi: 10.1016/j.phrs.2019.01.003. Epub 2019 Jan 3. Pharmacol Res. 2019. PMID: 30611855

10

Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid.

Rastegari A, Mottaghitalab F, Dinarvand R, Amini M, Arefian E, Gholami M, Atyabi F. Rastegari A, et al. Among authors: gholami m. Drug Deliv Transl Res. 2019 Jun;9(3):694-706. doi: 10.1007/s13346-019-00618-1. Drug Deliv Transl Res. 2019. PMID: 30825078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

764 results

Search Page